Life sciences

EnteroBiotix is pioneering treatments for diseases associated with imbalances of gut-dwelling microbes.

Next-generation cloud-based patient record system designed by clinicians, for clinicians.

Pertinax Pharma are leading the way in safer, more effective wound care.

MGB Biopharma aims to address the rapidly evolving health issue that is antimicrobial resistance with its lead compound, MGB-BP-3.

Lightpoint Medical is an innovative medical device company dedicated to improving health outcomes for cancer patients through molecular image-guided surgery.

Enabling earlier, more accurate, cancer detection.

Delivering high quality ion channel drug discovery and safety profiling services to the life sciences industry

Cambridge Nutraceuticals is expanding its health supplements business under its brand FutureYou. The company successfully overfunded on SyndicateRoom in January 2018.</p>

Momentum Bioscience overfunded on SyndicateRoom in November 2017. Read about the raise here.

Camallergy, the company helping people overcome food allergy, successfully raised business finance on SyndicateRoom in 2017.

Tomo, the App that manages the habits which help to maintain your mental wellbeing, successfully raised funds on SyndicateRoom in October 2017.

Digital Therapeutics tackles preventable chronic diseases with a new class of medicines. The company raised funds on SyndicateRoom in 2017.

Biotechspert aims to facilitate access to world-leading technical, scientific and commercial expertise. The company raised finance on SyndicateRoom.

Redecol, a company developing an asthma monitoring device to address the need for a new lung function test, succesfully raised funds on SyndicateRoom.

Re-Vana Therapeutics is a life science spin-out from Queen’s University Belfast. The company raised £1,104,593 on SyndicateRoom in September 2017.

ePatient Network provides rare disease patients with up-to-date scientific information, community insights and medical research and connects them with clinical trial opportunities through its Raremark platform.

Dem Dx is a diagnostic support tool for medical professionals that augments clinical diagnoses. Read about the company's successful raise here.

A drug development company engaged in the research and development of innovative medicines to control and potentially cure immuno-inflammatory diseases. Lead Investor, the DPTI Fund, seeks to help cutting edge science and technology firms.

Hibergene creates rapid, accurate and easy-to-use molecular diagnostics for infectious diseases.

Active Needle Technology has developed technology to help doctors perform needle based procedures with greater accuracy and reliability. Oxford Technology, an award-winning fund, specialising in start-up and early stage technology, is leading the round.

Orthogem is focused on the discovery and development of advanced synthetic bone graft. Find out more about Orthogem's raise here.

Cipher Surgical offers an innovative method of maintaining vision during a laparoscopic procedure. Read about Cipher Surgical's crowdfunding campaigns here.

Small Pharma is developing an oral rapid-acting antidepressant they believe could make a difference in the lives of those experiencing severe depression.

Jupiter Diagnostics is developing faster, cheaper and easier blood tests. Read about the Jupiter Diagnostics equity crowdfunding campaign here.

NALIA Systems overfunded to £491,844 (126% of its target) in September 2016 with the help of 78 investors.

OR Productivity produce simple and reliable tools that help surgeons become more efficient. Charles Breese, lead investor, has over 30 years' experience as a professional investor and fund manager.

SwabTech is an NHS spin-out developing a medical device to recover a patient’s own blood from swabs during surgery. It raised £580,000 on SyndicateRoom in 2016.

New hope for cancer patients, TC Biopharm Limited raised funds on SyndicateRoom. Read about the raise here.

Health supplements scientifically proven to deliver more of the good stuff to your body.

Microtest, a company making allergy testing faster, cheaper and easier, raised growth capital on SyndicateRoom in March 2016.

Nobel prize winning stem cell tech to produce quality human cells for biomedical research, Axol Bioscience Ltd raised on SyndicateRoom.

Generic Robotics' technology brings medical training closer to real life. Read about the company's funding round on SyndicateRoom here.

Patented break-through technology that has potential to transform the way diseases are treated, Cell Guidance Systems raised on SyndicateRoom.

The latest proven testing technologies and methodologies for early cancer detection, Check4Cancer successfully raised on SyndicateRoom.

Noxsudor aims to improve the quality of life of cancer patients suffering common side-effects.

Liverpool ChiroChem makes cost-efficient R&D chemicals for drug discovery. Read about its SyndicateRoom funding round.

Market leading technology that can solve one of the NHS' biggest problems, Time for Medicine raised on SyndicateRoom.

Electrospinning makes technology that can be used in 3D printing human tissue, such as an eye or joint. Find out about there funding round here.

Developing a unique wound healing device, focussed on saving diabetics from lower limb amputations. The global market for this product exceeds $1 billion.

The only product on the market that detects ovulation with 99% accuracy, Fertility Focus raised funds on SyndicateRoom. Read about the raise here.

New hope to thousands of Advanced Heart Failure patients at a cost health systems can afford.

Patented nutraceuticals for billion pound health markets. Their first product is already on sale in Holland & Barrett and Boots and via subscription.

Cipher Surgical offers an innovative method of maintaining vision during a laparoscopic procedure. Read about Cipher Surgical's crowdfunding campaigns here.

From kill to cure - revealing the medical potential of venom. Venomtech successfully raised funding through online early stage investment platform SyndicateRoom

Clinically proven at-home acne therapy for a £3.5bn market, Ambicare raised almost £1m on SyndicateRoom in total. Read about its rounds here.

Oval Medical Technologies have developed a unique self-injector that’s small and easy to use, especially by patients who are frightened of needles.

Simple and reliable tools that help surgeons be more productive and hospitals to save money.

MitoDys, researching holistic approaches to the treatment of Parkinson's disease, has successfully raised £150k from angels and sophisticated investors on SyndicateRoom.

Fertility Focus has successfully raised £511,500 from a number of business angels and sophisticated investors on SyndicateRoom to develop their fertility diagnosis and treatment equipment.

Bactest’s technology turns microbial activity into data, offering multiple industry applications. They raised £838,380.

Apta Biosciences – creators of a groundbreaking alternative to antibodies – came to SyndicateRoom for help closing their £1.55 million round. The spin-off from Japanese IT giant Fujitsu wound up breezing past their funding target, closing at an impressive £1,792,500.